HIV/AIDS HAART
Genetically distinct HIV-1 quasispecies persist during prolonged HAART
Published in AIDS Weekly, January 16th, 2006
According to recent research published in the journal AIDS, "Reservoirs of HIV-1 are a major obstacle to virus eradication. There is therefore a need to clearly understand the molecular nature of the virus populations that persist in patients with sustained suppression of plasma viremia on highly active antiretroviral therapy (HAART)."
"We performed a detailed analysis of the genotypes of HIV-1 quasispecies isolated from highly purified blood cell types taken from three selected patients with sustained undetectable viral loads on HAART for 7...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-01-16)
More Articles from AIDS Weekly
- HIV/AIDS HAART
M89I/V protease mutation linked to therapy failure in HIV-1 non-B subtypes - HIV/AIDS Mother-to-Child Transmission
ZDV plus 3TC is the most effective regimen in reducing mother-to-child HIV transmission - HIV/AIDS Pathogenesis
CD4 T cells physically lost with sustained HIV replication - HIV/AIDS Transmission
Vaginal cells are selectively permissive to X4 HIV entry - Adverse Drug Reaction
Antiretroviral toxicity may increase death rate from liver-related disease - Apoptosis
Anti-HIV drug inhibits T cell apoptosis by combating oxidative damage of mitochondria - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
